Sciformix will participate at this year’s World Drug Safety Congress to be held in Berlin, Germany from 8th to 9th September 2015. The event will provide a great opportunity to interact with industry leaders, peers and thought leaders on key aspects of pharmacovigilance, signal detection, clinical safety, and regulations and benefit risk management.
At the conference, our Global Vice President of Safety Operations, Dr. David Balderson will speak on the challenges in achieving excellence in drug safety. Some of the topics he will touch upon include:
- Rapid phase of evolution in PV over the past three years and the added level of complexity for most PV organizations
- The challenge of maintaining a cohesive global PV system
- Developing a robust QMS and sound CAPA management
- Taking more pragmatic approaches to managing the product portfolio
- Investing in innovation
The World Drug Safety Congress is a leading global conference held annually that touches on sectors like Drug Safety, Risk Management & Surveillance, Clinical Safety, Pharmacoepidemiology, Post Authorization Safety, Data Management, Patient Safety, QPPV and Pharmacovigliance.
This year’s edition is expected to attract over 150 drug safety professionals, 30+ of the industry’s latest speakers and representation across CROs, Data Solution providers, Drug Safety Solution Providers, Niche CROs, IT Solutions providers and consulting services.
Visit us at booth #1 or schedule a meeting with us (email@example.com) to learn more about the full range of our safety and risk management services from pharmacovigilance to aggregate reporting to signal detection & risk management.